{"cluster": 48, "subcluster": 58, "abstract_summ": "The median age was 71 years, which indicated that most death patients were elderly.It is recommended that cancer patients receiving antitumour treatments should have vigorous screening for COVID-19 infection and should avoid treatments causing immunosuppression or have their dosages decreased in case of COVID-19 coinfection.CONCLUSION: We think that COVID\u201019 patients with BPH had a low mortality rate and did not have a poor prognosis in this patient group.All hospitalized patients with confirmed and suspected SARS-CoV-2 infection between 16 March 2020, and 30 April 2020, were analyzed retrospectively.CONCLUSIONS: Cancer patients show deteriorating conditions and poor outcomes from the COVID-19 infection.", "title_summ": "Clinical characteristics of 82 death cases with COVID-19The clinical characteristics and mortal causes analysis of COVID-19 death patientsClinical features and outcomes of COVID\u201019 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 casesComparison of clinical and microbiological diagnoses for older adults with COVID-19 in Wuhan: a retrospective studyClinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaClinical Features of 85 Fatal Cases of COVID-19 from Wuhan.The factors predicting pneumonia in COVID-19 patients: preliminary results of a university hospital in Turkey.A Retrospective Observational Study", "title_abstract_phrases": "It is recommended that cancer patients receiving antitumour treatments should have vigorous screening for COVID-19 infection and should avoid treatments causing immunosuppression or have their dosages decreased in case of COVID-19 coinfection.The median age was 71 years, which indicated that most death patients were elderly.CONCLUSION: We think that COVID\u201019 patients with BPH had a low mortality rate and did not have a poor prognosis in this patient group.All hospitalized patients with confirmed and suspected SARS-CoV-2 infection between 16 March 2020, and 30 April 2020, were analyzed retrospectively.CONCLUSIONS: Cancer patients show deteriorating conditions and poor outcomes from the COVID-19 infection."}